Local Anesthetics Practice Questions

Q: Systemic toxicity is more common with which type of regional anesthesia?

Epidural anesthesia. **Explanation:** The primary factor determining **Local Anesthetic Systemic Toxicity (LAST)** is the total dose (mass) of the drug administered and the vascularity of the site. **Why Epidural Anesthesia is the correct answer:** Epidural anesthesia requires a significantly **higher volume and concentration** of local anesthetic (e.g., 15–20 mL) compared to spinal anesthesia (e.g., 2–3 mL) to achieve an adequate block. Furthermore, the epidural space contains an extensive network of **Batson’s venous plexuses**. The combination of a large drug mass and high vascularity increases the risk of accidental intravascular injection or rapid systemic absorption, leading to toxicity. **Why other options are incorrect:** * **Spinal Anesthesia:** This involves injecting a very small dose of drug directly into the subarachnoid space. The total drug mass is too low to cause systemic toxicity, even if it were absorbed into the bloodstream. The primary risk here is "Total Spinal" (respiratory arrest due to high block), not systemic toxicity. * **Both/Neither:** These are incorrect because the risk profile is distinctly different between the two techniques based on the pharmacological dose used. **High-Yield Clinical Pearls for NEET-PG:** * **Order of Systemic Absorption (Highest to Lowest):** Intravenous > Tracheal > Intercostal > Caudal > Epidural > Brachial Plexus > Sciatic/Femoral > Subcutaneous. (Mnemonic: **I** **T**hink **I** **C**an **E**at **B**ig **S**ubway **S**andwiches). * **Early signs of LAST:** Perioral numbness, metallic taste, tinnitus, and lightheadedness. * **Management:** The antidote of choice for LAST is **20% Lipid Emulsion (Intralipid).** * **Bupivacaine** is the most cardiotoxic local anesthetic.

Q: All of the following side effects can occur as a result of systemic absorption of lidocaine except?

Increased gastric motility.. **Explanation:** Systemic absorption of local anesthetics (LAs) like lidocaine primarily affects the Central Nervous System (CNS) and the Cardiovascular System (CVS) due to the blockade of sodium channels in these excitable tissues. **Why Option A is the Correct Answer:** Lidocaine actually **decreases gastric motility** and slows down intestinal transit. Systemic lidocaine is sometimes used intravenously to treat postoperative ileus because it has anti-inflammatory properties, but its direct effect on the smooth muscles of the gastrointestinal tract is inhibitory, not stimulatory. Therefore, "increased gastric motility" is not a side effect of lidocaine toxicity. **Analysis of Incorrect Options:** * **B. Tonic-clonic convulsions:** This is a classic sign of CNS toxicity. LAs initially inhibit inhibitory pathways in the brain, leading to excitatory symptoms like tremors and seizures (tonic-clonic). * **C. Decreased cardiac output:** At high systemic concentrations, lidocaine blocks sodium channels in the myocardium, leading to negative inotropy (decreased contractility), bradycardia, and eventually a drop in cardiac output. * **D. Respiratory depression:** As toxicity progresses, the initial CNS excitation is followed by generalized CNS depression. This leads to the depression of the medullary respiratory centers, resulting in apnea or respiratory arrest. **High-Yield Clinical Pearls for NEET-PG:** * **Order of Toxicity:** CNS symptoms (tinnitus, perioral numbness, seizures) usually precede CVS symptoms (arrhythmias, hypotension). * **Bupivacaine vs. Lidocaine:** Bupivacaine is significantly more cardiotoxic than lidocaine. * **Antidote:** Intravenous **Lipid Emulsion (Intralipid 20%)** is the specific treatment for Local Anesthetic Systemic Toxicity (LAST).

Q: What effect does adrenaline have when used with local anesthetics?

All of the above. Adrenaline (Epinephrine) is the most common adjuvant added to local anesthetics (LA). Its primary mechanism is **vasoconstriction** via $\alpha_1$-adrenergic receptors, which leads to several clinical benefits: 1. **Reduced Systemic Absorption:** By constricting local blood vessels, adrenaline slows the rate at which the LA enters the systemic circulation. This keeps the drug concentrated at the nerve site and reduces the risk of **Systemic Toxicity (LAST)**. 2. **Prolonged Duration of Action:** Since the drug remains at the site of injection for a longer period due to decreased vascular washout, the duration of the nerve block is significantly extended (especially for short and intermediate-acting LAs like Lidocaine). 3. **Increased Maximum Permissible Dose:** Because systemic absorption is slower, the body can metabolize the drug more effectively as it trickles into the blood. This allows clinicians to safely administer a higher total dose of the LA (e.g., the max dose of Lidocaine increases from **3 mg/kg to 7 mg/kg** when adrenaline is added). **Why "All of the Above" is correct:** Options A, B, and C are all direct consequences of adrenaline-induced vasoconstriction. It allows for a higher safe dose (A), limits blood uptake (B), and keeps the block active longer (C). **High-Yield Clinical Pearls for NEET-PG:** * **Standard Concentration:** Adrenaline is typically used in a concentration of **1:200,000** (5 µg/mL). * **Contraindications:** Avoid using adrenaline in "end-artery" areas (fingers, toes, nose, penis, and pinna of the ear) due to the risk of **ischemic necrosis/gangrene**. * **Marker of Intravascular Injection:** Adrenaline acts as a "test dose" marker; an accidental intravascular injection will cause an immediate spike in heart rate and blood pressure.

Q: A vial contains 4 ml of 2% lignocaine solution. How much lignocaine is present in 1 ml?

20 mg. ### Explanation **1. Understanding the Concept (The "Rule of 10")** In pharmacology, the concentration of a solution expressed as a percentage (%) represents the number of grams of a drug in 100 ml of solution. * A **1% solution** means 1 gram in 100 ml. * 1 gram = 1000 mg. Therefore, 1000 mg / 100 ml = **10 mg/ml**. To find the concentration in mg/ml quickly, simply **multiply the percentage by 10**. For a **2% lignocaine solution**: $2 \times 10 = \mathbf{20\text{ mg/ml}}$. The total volume of the vial (4 ml) is a distractor in this specific question because the query asks for the amount in **1 ml**, not the total vial. **2. Analysis of Incorrect Options** * **Option A (2 mg):** This is a common error where the student forgets to convert grams to milligrams or fails to account for the "per 100 ml" definition. * **Option B (8 mg):** This is likely calculated by multiplying the percentage (2) by the volume (4), which is mathematically incorrect for determining concentration. * **Option D (200 mg):** This would be the concentration of a 20% solution, or the total amount of drug if the vial were 10 ml. **3. Clinical Pearls & High-Yield Facts for NEET-PG** * **Maximum Dose of Lignocaine:** * Plain Lignocaine: **3 mg/kg** * Lignocaine with Adrenaline (1:200,000): **7 mg/kg** * **Adrenaline Concentration:** 1:200,000 corresponds to **5 mcg/ml**. Adding adrenaline increases the duration of action and reduces systemic toxicity by causing vasoconstriction. * **Mechanism of Action:** Lignocaine blocks voltage-gated **sodium ($Na^+$) channels** in the inactivated state. * **Order of Nerve Block:** Pain > Temperature > Touch > Deep Pressure > Motor.

Q: What was the first local anesthetic agent used in clinical anesthesia?

Cocaine. **Explanation:** **Cocaine** is the correct answer as it was the first local anesthetic used in clinical practice. It is a naturally occurring alkaloid derived from the leaves of the *Erythroxylon coca* plant. In **1884**, **Karl Koller**, an Austrian ophthalmologist, first demonstrated its clinical utility by using it for topical anesthesia during eye surgery. Shortly after, William Halsted used it to perform the first nerve block. **Analysis of Incorrect Options:** * **Procaine (Option D):** Synthesized by Alfred Einhorn in 1904, it was the first **synthetic** ester local anesthetic. It was developed to provide a less toxic alternative to cocaine. * **Lidocaine (Option C):** Synthesized by Nils Löfgren in 1943, it was the first **amide-linked** local anesthetic. It revolutionized the field due to its faster onset and greater stability compared to esters. * **Bupivacaine (Option A):** An amide anesthetic synthesized in 1957. It is known for its long duration of action and significant sensory-motor dissociation, but it was introduced much later than the others. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Local anesthetics work by blocking **voltage-gated sodium channels** on the inner surface of the nerve membrane. * **Unique Property:** Cocaine is the only local anesthetic that causes **vasoconstriction** (by inhibiting norepinephrine reuptake); all others are vasodilators (except ropivacaine/levobupivacaine which have mild vasoconstrictive effects). * **Metabolism:** **Esters** (Cocaine, Procaine) are metabolized by **pseudocholinesterase**, while **Amides** (Lidocaine, Bupivacaine) are metabolized in the **liver**. * **Rule of "i":** Amides have two "i"s in their name (L**i**doca**i**ne), while esters have only one (Coca**i**ne).

Q: During regional anesthesia, which of the following local anesthetic agents has the longest duration of action when used for peripheral nerve block?

Bupivacaine. ***Bupivacaine*** - **Bupivacaine** (and its stereoisomer, **levobupivacaine**) and **ropivacaine** are long-acting local anesthetics, but bupivacaine typically provides the longest duration of action for peripheral nerve blocks (4-12 hours). - The long duration is due to its high **lipid solubility** and high degree of **protein binding**, resulting in slow systemic absorption from the injection site. *Lidocaine* - Lidocaine is a **medium-potency, intermediate-duration** local anesthetic, typically lasting only 1-2 hours for peripheral nerve block unless combined with vasoconstrictors like epinephrine. - Its shorter duration compared to bupivacaine is due to its lower lipid solubility and lower protein binding. *Mepivacaine* - Mepivacaine is categorized as an intermediate-duration agent, similar to lidocaine, offering a slightly longer duration of action (approximately 1.5-3 hours) than lidocaine but significantly shorter than bupivacaine. - It has a faster onset than bupivacaine but a shorter duration, making it suitable when intermediate duration is preferred. *Procaine* - Procaine is an **ester-type** local anesthetic known for its rapid metabolism by plasma pseudocholinesterase, leading to a very short duration of action (less than 1 hour). - It is currently used less frequently for peripheral nerve blocks due to its short half-life and higher potential for allergic reactions.

Q: The composition of the given anesthetic product is:

2.5% lignocaine and 2.5% prilocaine. ***2.5% lignocaine and 2.5% prilocaine*** - The image clearly displays "emla 5 g cream". **EMLA (Eutectic Mixture of Local Anesthetics)** cream is a widely recognized topical anesthetic preparation. - EMLA cream is composed of a **eutectic mixture of 2.5% lidocaine (lignocaine) and 2.5% prilocaine**, making it a 5% total local anesthetic preparation. *5 % lignocaine and 5 % benzocaine* - While lignocaine is a common local anesthetic, **benzocaine** is also a local anesthetic but it's not a primary component of EMLA cream. - The combination of 5% lignocaine and 5% benzocaine is not the standard formulation for the product shown in the image. *5 % benzocaine and 5 % tetracaine* - **Benzocaine** and **tetracaine** are both local anesthetics, but this combination is incorrect for EMLA cream. - This pairing would constitute a different topical anesthetic product, not the one identified in the image. *5 % benzocaine and 5 % cocaine* - **Cocaine** is a local anesthetic, but it is also a powerful stimulant and has high abuse potential, making it unsuitable for general topical anesthetic creams due to its severe side effects and regulatory restrictions. - This combination is not found in common medical topical anesthetic preparations like EMLA cream.

Question 1

Increased risk of cardiotoxicity associated with local anesthetics requires a dose reduction in all of the following, except:

Accepted Answer

Increased cardiac output

Answer

Pregnancy

Answer

Acidosis

Answer

Pediatric patients

Question 2

If a patient has an absolute allergy to local anesthetics (LA), which drug is typically used as an alternative?

Accepted Answer

Diphenhydramine hydrochloride

Answer

Chlorpheniramine maleate

Answer

Benzalkonium chloride

Answer

Ketamine hydrochloride

Question 3

Systemic toxicity is more common with which type of regional anesthesia?

Accepted Answer

Epidural anesthesia

Answer

Spinal anesthesia

Answer

Both spinal and epidural anesthesia

Answer

Neither spinal nor epidural anesthesia

Question 4

All of the following side effects can occur as a result of systemic absorption of lidocaine except?

Accepted Answer

Increased gastric motility.

Answer

Tonic clonic convulsions.

Answer

Decreased cardiac output.

Answer

Respiratory depression.

Question 5

Which of the following is the preferred local anesthetic technique for hemophiliacs?

Accepted Answer

Intraligamentary

Answer

Nerve block

Answer

Supraperiosteal

Answer

Field block

Question 6

What effect does adrenaline have when used with local anesthetics?

Accepted Answer

All of the above

Answer

Increase the dose of local anesthetic required

Answer

Reduce systemic absorption of the local anesthetic

Answer

Prolong the duration of action of the local anesthetic

Question 7

A vial contains 4 ml of 2% lignocaine solution. How much lignocaine is present in 1 ml?

Accepted Answer

20 mg

Answer

2 mg

Answer

8 mg

Answer

200 mg

Question 8

What was the first local anesthetic agent used in clinical anesthesia?

Accepted Answer

Cocaine

Answer

Bupivacaine

Answer

Lidocaine

Answer

Procaine

Question 9

During regional anesthesia, which of the following local anesthetic agents has the longest duration of action when used for peripheral nerve block?

Accepted Answer

Bupivacaine

Answer

Procaine

Answer

Ropivacaine

Answer

Lignocaine (Lidocaine)

Question 10

The composition of the given anesthetic product is:

Accepted Answer

2.5% lignocaine and 2.5% prilocaine

Answer

5 % lignocaine and 5 % benzocaine

Answer

5 % benzocaine and 5 % tetracaine

Answer

5 % benzocaine and 5 % cocaine

Local Anesthetics — MCQs

Local Anesthetics — MCQs

On this page

Practice by Chapter

Want unlimited practice?